Home › Companies › PACIFIC BIOSCIENCES OF CALIFORNIA INC. › 2024-2025

PACIFIC BIOSCIENCES OF CALIFORNIA INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed June 6, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.

  • 6Ballot items
  • 214Asset managers
  • 916Fund votes
  • June 4, 2025Meeting date

Results at a glance

Meeting of June 4, 2025: 6 items on PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s Form 8-K, filed June 6, 2025: 3 elected · 3 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore PACIFIC BIOSCIENCES OF CALIFORNIA INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC.

These tallies are PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 6, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PACIFIC BIOSCIENCES OF CALIFORNIA INC. — official shareholder meeting results, meeting held June 4, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: William Ericson 104,132,46624,793,642809,854 --56,387,161 81%Elected—
Elect Director: Kathy Ordoñez 126,729,2732,137,971868,718 --56,387,161 98%Elected—
Elect Director: Christopher M. Smith 126,830,1612,076,866828,935 --56,387,161 98%Elected—
2. Ratification of the Appointment of Independent Registered Public Accounting Firm 162,154,84922,599,7391,368,535 ---- 88%Approved—
3. Advisory Vote on Approval of Named Executive Officer Compensation 78,367,53150,498,020870,411 --56,387,161 61%Approved—
4. Approval of Amendment to the 2020 Equity Incentive Plan 85,355,38243,563,859816,721 --56,387,161 66%Approved—

Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC., Form 8-K, filed with the SEC on June 6, 2025 — read the filing on EDGAR.

How asset managers voted at the PACIFIC BIOSCIENCES OF CALIFORNIA INC. 2024-2025 meeting

Each item below shows how the 214 asset managers that disclosed a PACIFIC BIOSCIENCES OF CALIFORNIA INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Christopher M. Smith

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 126,830,161AGAINST: 2,076,866
Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Christopher M. Smith

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Christopher M. Smith”): 126,830,161 for, 2,076,866 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 6,286,883 for, 119,722 against.

FOR
FOR: 6,286,883AGAINST: 119,722
Largest asset managers voting on “Election of Directors: Christopher M. Smith” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price879,9210 00For
Managed Portfolio Series758,2770 00For
Lincoln Financial390,5040 00For
Fidelity344,4490 00For
BlackRock284,2150 00For
Equitable265,2110 00For
Charles Schwab227,1350 00For
ARK Venture Fund197,1360 00For
Northern Trust173,7680 00For
Pacific Life138,0930 00For
AIG/SunAmerica134,0100 00For
Global X127,3940 00For
Bridge Builder Trust123,0290 00For
Investment Managers Series Trust II0119,722 00Against
Goldman Sachs105,6440 00For
Gabelli100,0000 00For
AMERICAN BEACON FUNDS89,0970 00For
SEI46,8000 00For
Invesco45,1840 00For
DWS42,4010 00For
ProShares40,4770 00For
State Street34,8320 00For
Nationwide27,7480 00For
Calvert26,0940 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

2. Elect Director: Kathy Ordoñez

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 126,729,273AGAINST: 2,137,971
Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: Kathy Ordonez

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: Kathy Ordoñez”): 126,729,273 for, 2,137,971 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 6,239,047 for, 167,558 against.

FOR
FOR: 6,239,047AGAINST: 167,558
Largest asset managers voting on “Election of Directors: Kathy Ordonez” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price879,9210 00For
Managed Portfolio Series758,2770 00For
Lincoln Financial375,23715,267 00For
Fidelity344,4490 00For
BlackRock284,2150 00For
Equitable265,2110 00For
Charles Schwab227,1350 00For
ARK Venture Fund197,1360 00For
Northern Trust173,7680 00For
Pacific Life138,0930 00For
AIG/SunAmerica134,0100 00For
Global X127,3940 00For
Bridge Builder Trust123,0290 00For
Investment Managers Series Trust II0119,722 00Against
Goldman Sachs105,6440 00For
Gabelli100,0000 00For
AMERICAN BEACON FUNDS89,0970 00For
SEI46,8000 00For
Invesco45,1840 00For
DWS42,4010 00For
ProShares40,4770 00For
State Street34,8320 00For
Nationwide27,7480 00For
Calvert26,0940 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

3. Elect Director: William Ericson

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST
FOR: 104,132,466AGAINST: 24,793,642
Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: Election of Directors: William Ericson

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“Elect Director: William Ericson”): 104,132,466 for, 24,793,642 against, per its Form 8-K filed June 6, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The four matters voted on at the Annual Meeting and the voting results with respect to each such matter are set forth below: Proposal 1: Election of Four Class III Directors Each director nominee was duly elected to serve until the 2026 annual meeting of stockholders and until his or her successor …”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 5,486,995 for, 919,610 against.

FORAGAINST
FOR: 5,486,995AGAINST: 919,610
Largest asset managers voting on “Election of Directors: William Ericson” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price879,9210 00For
Managed Portfolio Series758,2770 00For
Lincoln Financial375,23715,267 00For
Fidelity239,027105,422 00Mixed
BlackRock0284,215 00Against
Equitable217,76047,451 00Mixed
Charles Schwab227,1350 00For
ARK Venture Fund197,1360 00For
Northern Trust173,7680 00For
Pacific Life0138,093 00Against
AIG/SunAmerica134,0100 00For
Global X127,3940 00For
Bridge Builder Trust0123,029 00Against
Investment Managers Series Trust II0119,722 00Against
Goldman Sachs105,6440 00For
Gabelli100,0000 00For
AMERICAN BEACON FUNDS89,0970 00For
SEI46,8000 00For
Invesco45,1840 00For
DWS42,4010 00For
ProShares40,4770 00For
State Street34,8320 00For
Nationwide027,748 00Against
Calvert026,094 00Against

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

4. 4. Approval of Amendment to the 2020 Equity Incentive Plan

Official resultCOMPENSATIONReported outcome: Approved

66% Approved · of votes cast

FOR 66%AGAINST
FOR: 85,355,382AGAINST: 43,563,859
Details: description as filed, official tally, votes by 44 asset managers

Description as filed by funds: TO APPROVE THE AMENDMENT OF OUR 2020 EQUITY INCENTIVE PLAN.

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“4. Approval of Amendment to the 2020 Equity Incentive Plan”): 85,355,382 for, 43,563,859 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: Approval of Amendment to the 2020 Equity Incentive Plan”
Support: 66% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 4,179,563 for, 2,229,148 against.

FORAGAINST
FOR: 4,179,563AGAINST: 2,229,148
Largest asset managers voting on “TO APPROVE THE AMENDMENT OF OUR 2020 EQUITY INCENTIVE PLAN.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price0879,921 00Against
Managed Portfolio Series0758,277 00Against
Lincoln Financial199,398191,106 00Mixed
Fidelity344,4490 00For
BlackRock284,2150 00For
Equitable265,2110 00For
Charles Schwab227,1350 00For
ARK Venture Fund197,1360 00For
Northern Trust173,7680 00For
Pacific Life138,0930 00For
AIG/SunAmerica0134,010 00Against
Global X127,3940 00For
Bridge Builder Trust123,0290 00For
Investment Managers Series Trust II119,7220 00For
Goldman Sachs105,6440 00For
Gabelli0100,000 00Against
AMERICAN BEACON FUNDS89,0970 00For
SEI46,8000 00For
Invesco45,1840 00For
DWS042,401 00Against
ProShares040,477 00Against
State Street34,8320 00For
Nationwide27,7480 00For
Calvert026,094 00Against

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

5. 3. Advisory Vote on Approval of Named Executive Officer Compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 7 wordings of this item as funds reported it.

61% Approved · of votes cast

FOR 61%AGAINST
FOR: 78,367,531AGAINST: 50,498,020
Details: description as filed, official tally, votes by 213 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers.

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“3. Advisory Vote on Approval of Named Executive Officer Compensation”): 78,367,531 for, 50,498,020 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”
Support: 61% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 43 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price0879,921 00Against
Managed Portfolio Series0758,277 00Against
Lincoln Financial199,398191,106 00Mixed
Fidelity239,027105,422 00Mixed
BlackRock0284,215 00Against
Equitable217,76047,451 00Mixed
Charles Schwab0227,135 00Against
ARK Venture Fund197,1360 00For
Northern Trust0173,768 00Against
Pacific Life0138,093 00Against
AIG/SunAmerica0134,010 00Against
Global X0127,394 00Against
Bridge Builder Trust0123,029 00Against
Investment Managers Series Trust II0119,722 00Against
Goldman Sachs0105,644 00Against
Gabelli100,0000 00For
AMERICAN BEACON FUNDS89,0970 00For
SEI046,800 00Against
Invesco045,184 00Against
DWS042,401 00Against
ProShares040,477 00Against
State Street34,8320 00For
Nationwide027,748 00Against
Calvert026,094 00Against

Fund voting reports, all 43 managers: 2,683,940 for, 3,722,665 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 186 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Madrone Advisors, LLC20,941,9150 00For
EDMOND DE ROTHSCHILD HOLDING S.A.020,208,780 00Against
Nikko Asset Management Co., Ltd.09,565,331 00Against
State Street3,831,90652,091 00For
BlackRock405,5481,465,225 00Mixed
Jackson Square Partners, LLC01,518,068 00Against
Northern Trust01,259,144 00Against
T. Rowe Price01,208,167 00Against
ARK Investment Management LLC989,7660 00For
NORDEA INVESTMENT MANAGEMENT AB0955,349 00Against
HHLR ADVISORS, LTD.918,8920 00For
BOURNE LENT ASSET MANAGEMENT INC857,8550 00For
Casdin Capital, LLC0723,767 00Against
Vestmark Advisory Solutions, Inc.0659,750 00Against
Mirador Capital Partners LP00 508,7950Abstain
MELLON INVESTMENTS Corp0496,672 00Against
ArrowMark Colorado Holdings LLC0468,382 00Against
Universal-Investment-Gesellschaft mbH0408,700 00Against
Two Sigma0304,430 00Against
STATE OF MICHIGAN RETIREMENT SYSTEM0300,406 00Against
Senvest Management, LLC0288,879 00Against
GEODE CAPITAL MANAGEMENT, LLC255,6160 00For
UBS0239,375 00Against
Charles Schwab0227,152 00Against
AllianceBernstein217,7600 00For

Institutional-manager reports, all 186 managers: 29,059,560 for, 42,880,150 against, 509,295 abstained, 3,438 not voted. Showing the 25 largest; see all in the interactive database.

6. 2. Ratification of the Appointment of Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

88% Approved · of votes cast

FOR 88%
FOR: 162,154,849AGAINST: 22,599,739
Details: description as filed, official tally, votes by 43 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.

PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accounting Firm”): 162,154,849 for, 22,599,739 against — passed, per its Form 8-K filed June 6, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 43 asset managers below reported 6,406,605 for.

FOR
FOR: 6,406,605
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YE” at PACIFIC BIOSCIENCES OF CALIFORNIA INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,598,4920 00For
T. Rowe Price879,9210 00For
Managed Portfolio Series758,2770 00For
Lincoln Financial390,5040 00For
Fidelity344,4490 00For
BlackRock284,2150 00For
Equitable265,2110 00For
Charles Schwab227,1350 00For
ARK Venture Fund197,1360 00For
Northern Trust173,7680 00For
Pacific Life138,0930 00For
AIG/SunAmerica134,0100 00For
Global X127,3940 00For
Bridge Builder Trust123,0290 00For
Investment Managers Series Trust II119,7220 00For
Goldman Sachs105,6440 00For
Gabelli100,0000 00For
AMERICAN BEACON FUNDS89,0970 00For
SEI46,8000 00For
Invesco45,1840 00For
DWS42,4010 00For
ProShares40,4770 00For
State Street34,8320 00For
Nationwide27,7480 00For
Calvert26,0940 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Largest PACIFIC BIOSCIENCES OF CALIFORNIA INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 300,041,000 shares outstanding at the time of that meeting.

Fund voting reports: top PACIFIC BIOSCIENCES OF CALIFORNIA INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 0.53%
2T. Rowe Price 0.29%
3Managed Portfolio Series 0.25%
4Lincoln Financial 0.13%
5Fidelity 0.11%
6BlackRock 0.09%
7Equitable 0.09%
8Charles Schwab 0.08%
9ARK Venture Fund 0.07%
10Northern Trust 0.06%
Institutional-manager reports: top PACIFIC BIOSCIENCES OF CALIFORNIA INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers.”, 2024-2025
#Asset manager % of shares outstanding
1Madrone Advisors, LLC 6.98%
2EDMOND DE ROTHSCHILD HOLDING S.A. 6.74%
3Nikko Asset Management Co., Ltd. 3.19%
4State Street 1.29%
5BlackRock 0.62%
6Jackson Square Partners, LLC 0.51%
7Northern Trust 0.42%
8T. Rowe Price 0.40%
9ARK Investment Management LLC 0.33%
10NORDEA INVESTMENT MANAGEMENT AB 0.32%

Reported PACIFIC BIOSCIENCES OF CALIFORNIA INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

PACIFIC BIOSCIENCES OF CALIFORNIA INC. holdings and ownership disclosed for the 2024-2025 proxy season
Holder % outstanding Disclosure
ARK Investment Management LLC 12.42% 13G
Madrone Opportunity Fund, L.P. 8.96% DEF14A
BlackRock 7.82% 13F
SB Northstar LP 6.82% DEF14A
Vanguard Group 5.42% 13F
EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) 4.45% 13G
Gregory Boyd Penner 2.82% 13G
State Street 2.13% 13F
Geode Capital 2.11% 13F
Morgan Stanley 1.12% 13F

Percentages above are of 300,041,000 shares outstanding, as reported by PACIFIC BIOSCIENCES OF CALIFORNIA INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PACIFIC BIOSCIENCES OF CALIFORNIA INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.

At PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s shareholder meeting held June 4, 2025, in the 2024-2025 proxy season, 214 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 916 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s filing reports the proposal as approved, with 61% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PACIFIC BIOSCIENCES OF CALIFORNIA INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 6, 2025.

PACIFIC BIOSCIENCES OF CALIFORNIA INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.